vimarsana.com
Home
Live Updates
Zai Lab Announces Acceptance by China's NMPA of the BLA for
Zai Lab Announces Acceptance by China's NMPA of the BLA for
Zai Lab Announces Acceptance by China's NMPA of the BLA for Efgartigimod Alfa Injection (Subcutaneous Injection) for Patients with Generalized Myasthenia Gravis
SHANGHAI, China and CAMBRIDGE, Mass., July 10, 2023 -- Zai Lab Limited today announced that China’s National Medical Products Administration has accepted the Biologics License Application ...
Related Keywords
China ,
Taiwan ,
Japan ,
United States ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Hong Kong ,
Shanghai ,
Macau ,
Christine Chiou Lina Zhang ,
Harald Reinhart ,
Shaun Maccoun Xiaoyu Chen ,
Zai Lab ,
Zai Lab Limited ,
Zai Lab Forward ,
Exchange Commission ,
Drug Administration ,
Head Of Global Development ,
China National Medical Products Administration ,
Lab Limited ,
National Medical Products Administration ,
Biologics License Application ,
Global Development ,
Infectious Diseases ,
Greater China ,
Myasthenia Gravis ,
Private Securities Litigation Reform Act ,